H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 18.2 HKD 2.13% Market Closed
Market Cap: 108B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Relative Value

The Relative Value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 14.98 HKD. Compared to the current market price of 18.2 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
14.98 HKD
Overvaluation 18%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
52
vs Industry
15
Median 3Y
8
Median 5Y
8.6
Industry
2.5
Forward
8.2
vs History
88
vs Industry
16
Median 3Y
26.9
Median 5Y
29.3
Industry
21.8
Forward
24.2
vs History
87
vs Industry
14
Median 3Y
26.4
Median 5Y
30.3
Industry
16.1
vs History
vs Industry
15
Median 3Y
27.2
Median 5Y
29.6
Industry
23.8
vs History
60
vs Industry
20
Median 3Y
3.4
Median 5Y
3.8
Industry
2.1
vs History
50
vs Industry
17
Median 3Y
6.1
Median 5Y
6.5
Industry
2.7
Forward
6.3
vs History
52
vs Industry
26
Median 3Y
6.7
Median 5Y
7.2
Industry
5.2
vs History
74
vs Industry
14
Median 3Y
19
Median 5Y
20.3
Industry
13.5
Forward
16.9
vs History
77
vs Industry
16
Median 3Y
20.8
Median 5Y
22.7
Industry
16.8
Forward
18.4
vs History
84
vs Industry
20
Median 3Y
19.2
Median 5Y
22.1
Industry
15.2
vs History
82
vs Industry
18
Median 3Y
21.8
Median 5Y
24.5
Industry
19.3
vs History
42
vs Industry
11
Median 3Y
7.7
Median 5Y
8.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Hansoh Pharmaceutical Group Company Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
108B HKD 8.4 21.5 16.9 18.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average P/E: 31.1
21.5
33%
0.7
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average EV/EBITDA: 415.2
16.9
64%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average EV/EBIT: 1 811.9
18.5
68%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top